KRAS G12A Identifies a High-Risk Subset in Resected Stage II-III Colorectal Cancer.

Cancers (Basel) · 2025 · PMC12651688 · PMID 41300966

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

reported that G12C and G12V were predictive of poor OS in patients with recurrent and metastatic disease, and G12A also showed a trend toward poor OS [ 15 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.